10-Q: Bunge Global SA Reports Lower Q3 Earnings Amidst Market Shifts and Strategic Transactions

Sentiment:

Quarterly Report


Bunge Global SA's third-quarter earnings decreased compared to the previous year, influenced by lower segment EBIT and strategic business moves.

Capital raiseBunge completed the sale and issuance of three tranches of unsecured senior notes for an aggregate principal amount of $2.0 billion.Bunge secured a total of $8.0 billion in acquisition debt financing for the Viterra acquisition, which was reduced to $6.0 billion after the senior notes issuance.Bunge's wholly-owned subsidiary, BLFC, commenced US Exchange Offers to exchange all outstanding notes of certain series issued by VFBV for up to $1.95 billion aggregate principal amount of new notes issued by BLFC and guaranteed by Bunge.
Worse than expectedNet income attributable to Bunge shareholders decreased significantly compared to the same period last year.Diluted earnings per share decreased significantly compared to the same period last year.Total segment EBIT decreased significantly compared to the same period last year.

Summary

  • Bunge Global SA reported a net income attributable to shareholders of $221 million for the third quarter of 2024, a decrease from $373 million in the same period of 2023.
  • Diluted earnings per share were $1.56, down from $2.47 in the third quarter of the previous year.
  • Total segment EBIT for the quarter was $407 million, a decrease from $584 million in the third quarter of 2023.
  • The decrease in earnings was primarily due to lower segment EBIT in the core and non-core segments, particularly in the Agribusiness segment.
  • Net sales for the quarter were $12.9 billion, compared to $14.2 billion in the same period last year.
  • For the nine months ended September 30, 2024, net income attributable to Bunge shareholders was $535 million, a decrease from $1.627 billion in the same period of 2023.
  • Diluted earnings per share for the nine months were $3.73, down from $10.71 in the same period last year.
  • Total segment EBIT for the nine months was $1.025 billion, a decrease from $2.382 billion in the same period of 2023.
  • The company's working capital decreased to $8.228 billion at September 30, 2024, from $8.663 billion at December 31, 2023.
  • Bunge completed the sale and issuance of $2.0 billion in senior notes and prepaid a $750 million term loan.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While there are positive strategic moves and credit rating upgrades, the significant decrease in earnings and segment EBIT, along with the decrease in cash from operations, indicates a challenging quarter. The sentiment is therefore moderately negative.

Positives

  • Bunge's commercial paper program was increased by $1 billion to an aggregate of $2 billion.
  • Bunge secured a $3.2 billion 5-year revolving credit agreement maturing in 2029.
  • Bunge exercised the accordion provision in its $3.5 billion revolving facility agreement, increasing the total committed capacity to $3.5 billion upon completion of the Viterra acquisition.
  • Bunge extended the maturity date of its $1.1 billion 364-day revolving credit agreement to April 11, 2025.
  • Bunge's credit ratings were upgraded by Standard & Poor's, Moody's, and Fitch.

Negatives

  • Net sales decreased by 8% in the Agribusiness segment in Q3 2024 compared to Q3 2023.
  • Gross profit decreased by 39% in the Agribusiness segment in Q3 2024 compared to Q3 2023.
  • Net sales decreased by 12% in the Refined and Specialty Oils segment in Q3 2024 compared to Q3 2023.
  • Net sales decreased by 15% in the Milling segment in Q3 2024 compared to Q3 2023.
  • Sugar and Bioenergy segment EBIT decreased by 89% in Q3 2024 compared to Q3 2023.
  • Cash provided by operating activities decreased by $1.013 billion for the nine months ended September 30, 2024, compared to the same period in 2023.

Risks

  • The war in Ukraine and related sanctions on Russia could impact Bunge's operations and facilities.
  • Weather conditions and crop/animal diseases could affect Bunge's business.
  • Global and regional economic, agricultural, financial, and political conditions could impact Bunge.
  • Changes in government policies and laws could affect Bunge's business.
  • Bunge's ability to complete and integrate acquisitions, including the Viterra acquisition, is a risk.
  • Fluctuations in supply, demand, and prices for agricultural commodities and other raw materials could impact Bunge.
  • Operational risks, including industrial accidents, natural disasters, and cybersecurity incidents, could affect Bunge.
  • Changes in foreign exchange policy or rates could impact Bunge.
  • Bunge's dependence on third parties is a risk.
  • Bunge's ability to attract and retain key personnel is a risk.

Future Outlook

The company expects the Viterra acquisition to close in the next several months, subject to regulatory approvals and other customary closing conditions. Bunge also intends to use proceeds from the Senior Notes issuance to fund a portion of the cash consideration for the Viterra acquisition and to repay a portion of certain Viterra debt.

Management Comments

  • Management believes that the condensed consolidated financial statements reflect the largest amount of tax benefit that is more likely than not to be realized.
  • Management does not expect legal matters to have a material adverse effect on Bunge's financial condition, results of operations, or liquidity.
  • Bunge's management believes Total Segment EBIT is a useful measure of operating profitability, since the measure allows for an evaluation of the performance of its segments without regard to its financing methods or capital structure.

Industry Context

The report reflects the challenges faced by agribusiness companies due to fluctuating commodity prices and global economic conditions. The strategic moves, such as the Viterra acquisition and divestitures, indicate a focus on optimizing the company's portfolio and positioning for future growth in a complex market.

Comparison to Industry Standards

  • Bunge's performance in Q3 2024 reflects a broader trend of decreased earnings in the agribusiness sector due to market volatility and price stabilization after a period of high prices.
  • Compared to competitors like Archer Daniels Midland (ADM) and Cargill, Bunge's Q3 results show a similar pattern of lower earnings, although specific segment performance varies across companies.
  • The strategic acquisition of Viterra is a significant move, potentially positioning Bunge to compete more effectively with larger global players in the long term, similar to how ADM has expanded its global reach through acquisitions.
  • Bunge's focus on sustainability, as evidenced by the sustainability provisions in its credit facilities, aligns with increasing industry emphasis on environmentally responsible practices, similar to initiatives undertaken by other major agribusiness firms.
  • The divestiture of BP Bunge Bioenergia is a strategic move to streamline operations, which is a common practice among agribusiness companies to focus on core competencies, similar to how other companies have divested non-core assets.

Related Party Transactions

  • Bunge purchases agricultural commodity products from certain of its unconsolidated investees and other related parties, comprising approximately 9% or less of total Cost of goods sold.
  • Bunge sells agricultural commodity products to certain of its unconsolidated investees and other related parties, comprising approximately 2% or less of total Net sales.
  • Bunge receives services from and provides services to its unconsolidated investees and other related parties, including tolling, port handling, administrative support, and other services.
  • Bunge provides certain advance payments for future delivery of specified quantities of agricultural commodities and advances to its unconsolidated investees.

Stakeholder Impact

  • Shareholders will be impacted by the decrease in earnings and diluted earnings per share.
  • Employees may be affected by the ongoing migration of processes to shared business service models.
  • Customers and suppliers may be impacted by the strategic changes and divestitures.
  • Creditors will be impacted by the new debt issuances and changes in credit ratings.

Next Steps

  • Bunge expects to close the Viterra acquisition in the next several months.
  • Bunge intends to use proceeds from the Senior Notes issuance to fund a portion of the cash consideration for the Viterra acquisition and to repay a portion of certain Viterra debt.
  • Bunge plans to continue migrating certain processes to shared business service models.
  • Bunge intends to offer a lump sum buyout to eligible participants and terminate a defined benefit U.S. pension plan in the second half of fiscal year 2025.

Key Dates

DateDescription
June 13, 2023Bunge entered into a definitive business combination agreement with Viterra Limited.
October 5, 2023Bunge shareholders approved the acquisition of Viterra.
October 10, 2023Bunge entered into a definitive share purchase agreement to acquire CJ Latam and CJ Selecta.
February 22, 2024Bunge's 2023 Annual Report on Form 10-K was filed with the SEC.
March 1, 2024Bunge entered into a $3.2 billion 5-year revolving credit agreement and exercised the accordion provision in its $3.5 billion revolving facility agreement.
March 26, 2024Bunge entered into a stock purchase agreement with Repsol to divest 40% of Bunge Iberica SA.
April 12, 2024Bunge increased the size of its commercial paper program and amended its $1.1 billion 364-day revolving credit agreement.
May 15, 2024Shareholders of Bunge Global SA approved a cash dividend distribution of $2.72 per share.
June 19, 2024Bunge entered into a share purchase agreement to sell its 50% ownership share in BP Bunge Bioenergia.
September 9, 2024Bunge announced the commencement of US Exchange Offers for Viterra notes.
September 17, 2024Bunge completed the sale and issuance of $2.0 billion in senior notes.
September 30, 2024Bunge prepaid and terminated its 3-year term loan agreement due in 2025.
October 1, 2024Bunge closed the transaction to sell its 50% ownership share in BP Bunge Bioenergia.
October 2, 2024Bunge utilized $377 million of plan assets to purchase a buy-in contract for one of its defined benefit U.S. pension plans.
October 22, 2024Bunge notified plan participants of its intent to offer a lump sum buyout and terminate a defined benefit U.S. pension plan.
October 30, 2024Date of the filing of the Form 10-Q.

Keywords

Agribusiness, Refined and Specialty Oils, Milling, Sugar and Bioenergy, Commodities, Derivatives, Debt, Acquisition, Viterra, Financial Results, Earnings, Share Repurchase, Credit Facilities, Senior Notes

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.